$406.67
+11.05
(+2.79%)
As of Oct 15, 2026, 9:55 PM EDT
Price history
Today's analyst average
Analyst average over timeIndividual analyst targets
Analyst history starts Jun 5, 2026, the first target we tracked for UNH.
UnitedHealth Group (UNH) is trading up at $406.67 (+2.79%) on NYSE/NASDAQ, as of the latest quote. It is a S&P 500 constituent in the Health Care sector.
Analyst price targets on UNH
Current price targets from 13 firms average $483, median $495, ranging from $402 to $529 — the average is 19% above the current $407. Each is tracked to its date and scored the same way a member's call is.
- Baird $389 → $427 by Oct 2027 Oct 14, 2026 via GuruFocus · Baird's track record
- TD Cowen $379 → $402 by Oct 2027 Oct 9, 2026 via GuruFocus · TD Cowen's track record
- Cantor Fitzgerald $379 → $495 by Sep 2027 Sep 11, 2026 via Investing.com · Cantor Fitzgerald's track record
- Bernstein $436 → $512 by Jul 2027 Jul 21, 2026 via Investing.com Canada · Bernstein's track record
- Mizuho $422 → $493 by Jul 2027 Jul 20, 2026 via Investing.com · Mizuho's track record
- Bank of America $422 → $512 by Jul 2027 Jul 20, 2026 via Investing.com · Bank of America's track record
- Barclays $422 → $441 by Jul 2027 Jul 20, 2026 via GuruFocus · Barclays's track record
- Oppenheimer $426 → $500 by Jul 2027 Jul 17, 2026 via GuruFocus · Oppenheimer's track record
- Morgan Stanley $426 → $529 by Jul 2027 Jul 17, 2026 via GuruFocus · Morgan Stanley's track record
- KeyBanc Capital Markets $426 → $500 by Jul 2027 Jul 17, 2026 via GuruFocus · KeyBanc Capital Markets's track record
- Truist Securities $426 → $500 by Jul 2027 Jul 17, 2026 via GuruFocus · Truist Securities's track record
- RBC Capital Markets $426 → $478 by Jul 2027 Jul 17, 2026 via GuruFocus · RBC Capital Markets's track record
Targets published by research firms, extracted from the news, checked against independent reporting, and linked to their source. Where a firm did not state a horizon the target is tracked as 12 months, the industry convention; the rows where the firm set its own horizon are marked. Reported here as facts about what was published — not recommendations from Dalsna Finance, and no firm listed is affiliated with this site.
UnitedHealth Group revenue & net income history (FY2016–FY2025)
RevenueNet incomeNet margin (right axis, %)
| FY2016Dec 2016 | FY2017Dec 2017 | FY2018Dec 2018 | FY2019Dec 2019 | FY2020Dec 2020 | FY2021Dec 2021 | FY2022Dec 2022 | FY2023Dec 2023 | FY2024Dec 2024 | FY2025Dec 2025 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $184.8B | $201.2B | $226.2B | $242.2B | $257.1B | $287.6B | $324.2B | $371.6B | $400.3B | $447.6B |
| Growth (year over year) | +17.7% | +8.8% | +12.5% | +7.0% | +6.2% | +11.8% | +12.7% | +14.6% | +7.7% | +11.8% |
| Gross profit | $160.4B | $177.0B | $199.2B | $214.0B | $226.4B | $256.6B | $290.5B | $332.9B | $353.6B | $396.9B |
| Gross margin | 86.8% | 88.0% | 88.1% | 88.4% | 88.0% | 89.2% | 89.6% | 89.6% | 88.3% | 88.7% |
| Operating income | $12.9B | $15.2B | $17.3B | $19.7B | $22.4B | $24.0B | $28.4B | $32.4B | $32.3B | $19.0B |
| Operating margin | 7.0% | 7.6% | 7.7% | 8.1% | 8.7% | 8.3% | 8.8% | 8.7% | 8.1% | 4.2% |
| Net income | $7.02B | $10.6B | $12.0B | $13.8B | $15.4B | $17.3B | $20.1B | $22.4B | $14.4B | $12.1B |
| Net margin | 3.8% | 5.2% | 5.3% | 5.7% | 6.0% | 6.0% | 6.2% | 6.0% | 3.6% | 2.7% |
| EPS (diluted) | $7.25 | $10.72 | $12.19 | $14.33 | $16.03 | $18.08 | $21.18 | $23.86 | $15.51 | $13.23 |
| Balance sheet | ||||||||||
| Cash and equivalents | $10.4B | $12.0B | $10.9B | $11.0B | $16.9B | $21.4B | $23.4B | $25.4B | $25.3B | $24.4B |
| Total assets | $122.8B | $139.1B | $152.2B | $173.9B | $197.3B | $212.2B | $245.7B | $273.7B | $298.3B | $309.6B |
| Total liabilities | $82.6B | $87.0B | $96.0B | $111.7B | $126.8B | $135.7B | $159.4B | $174.8B | $195.7B | $207.9B |
| Long-term debt | $25.8B | $28.8B | $34.6B | $36.8B | $38.6B | $42.4B | $54.5B | $58.3B | $72.4B | $72.3B |
| Shareholders' equity | $38.2B | $49.8B | $54.3B | $60.4B | $68.3B | $75.0B | $81.5B | $94.4B | $98.3B | $100.1B |
| Cash flow | ||||||||||
| Operating cash flow | $9.79B | $13.6B | $15.7B | $18.5B | $22.2B | $22.3B | $26.2B | $29.1B | $24.2B | $19.7B |
| Capital expenditure | $1.71B | $2.02B | $2.06B | $2.07B | $2.05B | $2.45B | $2.80B | $3.39B | $3.50B | $3.62B |
| Free cash flow | $8.09B | $11.6B | $13.7B | $16.4B | $20.1B | $19.9B | $23.4B | $25.7B | $20.7B | $16.1B |
| Dividends paid | $2.26B | $2.77B | $3.32B | $3.93B | $4.58B | $5.28B | $5.99B | $6.76B | $7.53B | $7.92B |
| Share buybacks | $1.28B | $1.50B | $4.50B | $5.50B | $4.25B | $5.00B | $7.00B | $8.00B | $9.00B | $5.54B |
RevenueNet incomeNet margin (right axis, %)
| Q3 FY24Sep 2024 | Q4 FY24†Dec 2024 | Q1 FY25Mar 2025 | Q2 FY25Jun 2025 | Q3 FY25Sep 2025 | Q4 FY25†Dec 2025 | Q1 FY26Mar 2026 | Q2 FY26Jun 2026 | |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $100.8B | $100.8B | $109.6B | $111.6B | $113.2B | $113.2B | $111.7B | $112.0B |
| Growth (year over year) | +9.2% | +6.8% | +9.8% | +12.9% | +12.2% | +12.3% | +2.0% | +0.4% |
| Gross profit | $89.0B | $88.3B | $97.2B | $98.6B | $100.6B | $100.5B | $98.9B | $98.7B |
| Gross margin | 88.3% | 87.6% | 88.7% | 88.3% | 88.9% | 88.8% | 88.5% | 88.1% |
| Operating income | $8.71B | $7.77B | $9.12B | $5.15B | $4.32B | $380.0M | $8.99B | $7.99B |
| Operating margin | 8.6% | 7.7% | 8.3% | 4.6% | 3.8% | 0.3% | 8.0% | 7.1% |
| Net income | $6.05B | $5.54B | $6.29B | $3.41B | $2.35B | $10.0M | $6.28B | $5.48B |
| Net margin | 6.0% | 5.5% | 5.7% | 3.1% | 2.1% | 0.0% | 5.6% | 4.9% |
| EPS (diluted) | $6.51 | $5.99 | $6.85 | $3.74 | $2.59 | $0.05 | $6.90 | $6.04 |
| Balance sheet | ||||||||
| Cash and equivalents | $32.4B | $25.3B | $30.7B | $28.6B | $27.2B | $24.4B | $28.0B | $28.6B |
| Total assets | $299.3B | $298.3B | $309.8B | $308.6B | $315.3B | $309.6B | $312.6B | $309.7B |
| Total liabilities | $194.9B | $195.7B | $204.6B | $203.8B | $209.5B | $207.9B | $207.3B | $203.8B |
| Long-term debt | $74.1B | $72.4B | $71.3B | $73.5B | $72.4B | $72.3B | $71.4B | $69.5B |
| Shareholders' equity | $99.9B | $98.3B | $100.8B | $100.5B | $101.6B | $100.1B | $103.9B | $104.5B |
| Cash flow | ||||||||
| Operating cash flow | $13.9B | $2.37B | $5.46B | $7.19B | $5.95B | $1.11B | $8.91B | $11.1B |
| Capital expenditure | $991.0M | $912.0M | $898.0M | $886.0M | $890.0M | $948.0M | $763.0M | $799.0M |
| Free cash flow | $13.0B | $1.46B | $4.56B | $6.30B | $5.05B | $160.0M | $8.15B | $10.3B |
| Dividends paid | $1.94B | $1.93B | $1.91B | $2.00B | $2.00B | $2.00B | $2.00B | $2.09B |
| Share buybacks | $956.0M | $4.97B | $3.00B | $2.54B | $0 | $0 | $0 | $1.65B |
From UnitedHealth Group's 10-K and 10-Q filings with the SEC; its fiscal year ends in December. Each period shows the latest figure the company has reported for it, including restatements. Net margin is our own calculation from those reported figures (net income ÷ revenue); it is left blank where revenue is zero or missing. † Quarter derived from the company's year-to-date or full-year totals. Filings on SEC EDGAR →
About UnitedHealth Group
UnitedHealth Group Incorporated is an American multinational company based in Eden Prairie, Minnesota, specializing in health insurance and health care services. Selling insurance products under UnitedHealthcare, and health care services under the Optum brand, it is the world's nineth-largest company by revenue and the largest health care company by revenue. The company is ranked fourth on the 2026 Fortune Global 500.
Source: Wikipedia — UnitedHealth Group
- Headquarters
- Eden Prairie, Minnesota From SEC filings, Oct 2026
Recent News (20)
-
UnitedHealth Fell 51.32%, Then Rose 40.64%. DIA's Exposure Followed Both Moves by Design - 24/7 Wall St. UnitedHealth Fell 51.32%, Then Rose 40.64%. DIA's Exposure Followed Both Moves by Design 24/7 Wall St.
-
-
UnitedHealth Group Incorporated (UNH) Stock Forecasts UnitedHealth Group Incorporated (UNH) Stock Forecasts Yahoo Finance
-
UnitedHealth Stock Moves Higher: What's Going On? UnitedHealth Stock Moves Higher: What's Going On? Benzinga
-
Can UNH's Focus on Special Needs Plans Strengthen Medicare Growth? Can UNH's Focus on Special Needs Plans Strengthen Medicare Growth? The Globe and Mail
-
-
-
-
-
UnitedHealth Beats on Earnings, But Investors Question Growth Path UnitedHealth Beats on Earnings, But Investors Question Growth Path MarketBeat
-
-
-
-
-
-
-
-
-
Unitedhealth Group Inc Stock (UNH) Opened Up by 4.62% on Oct 14: What Investors Need To Know Unitedhealth Group Inc Stock (UNH) Opened Up by 4.62% on Oct 14: What Investors Need To Know TradingKey
-
More Health Care stocks
- SYK Stryker Corporation
- TECH Bio-Techne
- TMO Thermo Fisher Scientific
- UHS Universal Health Services
- VEEV Veeva Systems
- VRTX Vertex Pharmaceuticals
- VTRS Viatris
- WAT Waters Corporation